DEAFinal Rule

Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I

HealthcareOther

Summary

The Drug Enforcement Administration (DEA) has officially classified 4-fluoroamphetamine as an illegal drug in the most restrictive category, meaning it cannot be legally made, sold, or possessed in the United States. This action was taken because the drug poses serious health risks and is being misused as a street drug.

Key Points

  • 14-fluoroamphetamine is now classified as a Schedule I controlled substance, the same legal category as heroin and LSD, indicating it has high potential for abuse and no accepted medical use
  • 2Manufacturing, distributing, or possessing 4-fluoroamphetamine is now a federal crime subject to significant criminal penalties
  • 3The regulation targets both drug dealers and users, as possession of any amount is illegal without specific DEA permission
  • 4This action responds to the emerging street drug market, where 4-fluoroamphetamine has been sold as a dangerous synthetic stimulant
  • 5Law enforcement agencies now have clear legal authority to investigate and prosecute cases involving this substance

Impact Assessment

If you are a manufacturer or importer/exporter, this means you cannot legally produce, import, or distribute 4-fluoroamphetamine in any quantity in the United States.

Impact Level
Moderate
Geographic Scope

National

Compliance Cost

Minimal

Who is Affected
Healthcare ProvidersManufacturersImporters/Exporters

Key Dates

Published

January 15, 2026

Regulatory Connections

Amends CFR Sections
21 CFR Part 1308

This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.